{
  "id": 5432,
  "text": "J Clin Oncol 2017;35:4035-4041.Available at: https://www.ncbi.nlm.nih.gov/pubmed/29095678.251.Chung HC, Schellens JH, Delord J-P, et al.Pembrolizumab treatment of advanced cervical cancer: Updated results from the phase 2 KEYNOTE158 study [abstract].",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: J Clin Oncol 2017;35:4035-4041.Available at: https://www.ncbi.nlm.nih.gov/pubmed/29095678.251.Chung HC, Schellens JH, Delord J-P, et al.Pembrolizumab treatment of advanced cervical cancer: Updated results from the phase 2 KEYNOTE158 study [abstract].\n\n<question>: ",
  "ChatGPT_response_0": "根据J Clin Oncol 2017年的临床研究结果显示，Pembrolizumab治疗晚期宫颈癌在患者中具有一定的疗效。该疗法在KEYNOTE158研究中展示出一定的治疗效果，但具体效果可能会因患者个体差异而有所不同。需要更多的研究和数据支持来确认其在患者中具有显著的疗效。",
  "query": "这个临床研究中，Pembrolizumab治疗晚期宫颈癌的结果是否表明这种疗法在患者中具有显著的疗效？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这个临床研究中，Pembrolizumab治疗晚期宫颈癌的结果是否表明这种疗法在患者中具有显著的疗效？\n\n<reference text>: J Clin Oncol 2017;35:4035-4041.Available at: https://www.ncbi.nlm.nih.gov/pubmed/29095678.251.Chung HC, Schellens JH, Delord J-P, et al.Pembrolizumab treatment of advanced cervical cancer: Updated results from the phase 2 KEYNOTE158 study [abstract].\n\n<reply>: ",
  "response": "根据J Clin Oncol 2017年的临床研究结果显示，Pembrolizumab治疗晚期宫颈癌在患者中具有一定的疗效。该疗法在KEYNOTE158研究中展示出一定的治疗效果，但具体效果可能会因患者个体差异而有所不同。需要更多的研究和数据支持来确认其在患者中具有显著的疗效。"
}